STOCK TITAN

STEMSATION INTL INC - STSN STOCK NEWS

Welcome to our dedicated page for STEMSATION INTL news (Ticker: STSN), a resource for investors and traders seeking the latest updates and insights on STEMSATION INTL stock.

StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. Their flagship product, StemRCM, is a dietary supplement that aids stem cells in repairing, renewing, and restoring tissues and organ function by promoting healthy stem cell release, circulation, and migration. Through independent wellness advocates, the company directly sells its products to consumers. StemSation International is headquartered in Boca Raton, Florida.

Rhea-AI Summary

StemSation International (OTC: STSN) has executed a Letter of Intent to acquire 100% of Gorilla Marketing Group, (GMG), a private marketing company. GMG owns and distributes high-end vape products under the AlienHouse brand, including disposable vape cartridges and THC-P hemp derivatives. The acquisition aligns with StemSation's focus on the consumer goods space, particularly in convenience store impulse buy areas.

Key points:

  • GMG management will join StemSation upon completion
  • Definitive agreements and audited financials are required
  • Acquisition expected to be completed by year-end
  • StemSation aims to seek additional companies for growth
  • Convenience stores saw record in-store sales of $327.6 billion in 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.05%
Tags
-
Rhea-AI Summary

StemSation International (OTC: STSN), a South-Florida based company, has provided corporate updates on their expanded business model. The company, which has licensed technology for flavored, canned oxygen products, is exploring new business initiatives. CEO Benjamin Silber stated that while they initially targeted green energy companies for acquisition, they are now focusing on opportunities in the consumer goods sector, particularly 'impulse buy' products for convenience store cash registers.

This shift aligns with recent data from the National Association of Convenience Stores (NACS), which reported record sales of $859.8 billion in 2023, including $327.6 billion from in-store sales. StemSation aims to leverage the sales advantage of register space, where customers have already committed to making a purchase. The company expects to provide additional updates on their business plan shortly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
StemSation International announces strategic acquisition planning in the green energy space, focusing on solar energy companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.18%
Tags
Rhea-AI Summary

StemSation International (OTC PINK:STSN) has received registration for four trademarks from the United States Patent & Trademark Office through its subsidiary, StemSation IP Holding LLC. The trademarks include StemSation, StemRCM, ProStem PSP, and StemFlex. President Ray Carter emphasized the significance of this achievement for building a strong intellectual property portfolio. The company is expanding globally, with plans to enter Latin American markets by the end of 2021. StemSation develops all-natural wellness products focused on stem cells and endocannabinoids, marketed through Independent Wellness Advocates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.71%
Tags
none
-
Rhea-AI Summary

StemSation International, Inc. (OTC PINK:STSN) reported a 24% increase in revenues for Q2 2020, totaling $65,405 compared to $52,675 in Q1 2020. The company also reduced overhead costs by 18% as start-up expenses subsided. President & CEO Ray Carter expressed optimism about continued growth and marketing expansion despite challenges posed by COVID-19. StemSation is focused on natural health products that support stem cell and endocannabinoid systems and aims to enter Latin American markets by the end of 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

StemSation International (OTC: STSN) has partnered with First Class Alliance (FCA), a leading digital marketing agency, to enhance its online presence amidst a rapidly growing market for CBD products. This collaboration aims to boost brand awareness and improve consumer engagement. The global CBD market is projected to rise from $9.2 billion in 2020 to over $23.6 billion by 2025. Additionally, bone and joint health concerns are increasing, particularly among aging populations. StemSation focuses on developing natural wellness products that target stem cell and endocannabinoid systems.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.98%
Tags
none

FAQ

What is the current stock price of STEMSATION INTL (STSN)?

The current stock price of STEMSATION INTL (STSN) is $0.025 as of October 15, 2024.

What is the market cap of STEMSATION INTL (STSN)?

The market cap of STEMSATION INTL (STSN) is approximately 6.0M.

What does StemSation International, Inc. do?

StemSation International develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body.

What is StemRCM?

StemRCM is a dietary supplement offered by StemSation International that supports stem cells in repairing, renewing, and restoring tissues and organ function through healthy stem cell release, circulation, and migration.

How does StemSation International sell its products?

The company sells its products through independent wellness advocates directly to consumers.

Where is StemSation International headquartered?

StemSation International is headquartered in Boca Raton, Florida.

What is the latest news from StemSation International?

The company is strategically planning acquisitions in the green energy sector, with a focus on licensing opportunities and asset acquisitions.

STEMSATION INTL INC

OTC:STSN

STSN Rankings

STSN Stock Data

6.01M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Boca Raton